VIR Sale Disclosure
De Verneuil Vanina · SEC Form 4 · Filed Nov 4, 2026
Sale
Calculated transaction value
$26.72K
De Verneuil Vanina EVP, General Counsel, Corp Sec
VIR
Transaction date
Nov 3, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 1 day later
VIR daily price context
Close on/before transaction
$11.22
Nov 3, 2026
First close after public filing
$11.77
Nov 4, 2026
Return after filing · so far
+3.74%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,407 shares @ $11.1
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-070025
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$41.94K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vir Biotechnology, Inc. VIR Current | Sale | Nov 3, 2026 | $26.72K |
| Vir Biotechnology, Inc. VIR | Sale | Nov 2, 2026 | $15.22K |